Piramal Pharma Solutions appoints new chief operating officer
22 June 2022 -

The Pharma Solutions business of India-based Piramal Pharma Limited announced on Tuesday that it has appointed Herve Berdou as its new chief operating officer, Piramal Pharma Solutions (PPS).

Berdou has served as the global head of Operations, Cell and Gene Technologies at Lonza, He has over two decades of experience across global supply chain, procurement, and operations, including manufacturing and site head positions at both small and large facilities. He has worked with various prominent pharmaceutical companies, including AstraZeneca & MedImmune and Novartis.

Peter DeYoung, Piramal Pharma Solutions chief executive officer, said, 'I welcome Herve to PPS and wish him all the success in the new role. His broad, in-depth industry and functional expertise will help us create value for all our stakeholders as we continue our journey of profitable growth. His blend of CDMO and innovative pharmaceutical company experience positions him to understand and meet the needs of our customers and their patients. His multi-country operating track record will bring the best of our team and site network to our clients as we deliver integrated projects and support their clinical progression and commercial success. Herve's management style is aligned to our values and our cultural priorities.'